Small Change, Large Impact: The FDA’s Final Guidance On Premarket Submissions For SAMD/SIMD

Quality and regulatory expert Eric Henry spoke to Medtech Insight about the impact of the changes between the draft and final versions of the US FDA’s SIMD/SAMD premarket guidance document.